AnalystsInsight

Dave Rochester (Cantor Fitzgerald): Analyst Track Record and Price‑Target Accuracy

How often Dave Rochester’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 416 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

What changed since Oct 12

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

#969 rank (was #898)

Key takeaways

  • Dave Rochester ranks #861 of 1,000 analysts in Exent’s scoring (4.6★).
  • 53.9% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 148 days; 67.1% of calls were up 12 months later.
  • Most‑covered stocks: CFR, MTB, FLG, PB.
  • Free on Exent: Dave Rochester’s full record, with ratings 3 days after publication.

Dave Rochester’s track record at a glance

Dave Rochester of Cantor Fitzgerald ranks #861 of the 1,000 analysts Exent scores, with a 4.6★ rating and a focus on financials. Over a 7‑year lookback, 53.9% of Dave’s price targets were reached, 1.5 points above the 52.4% average across all analysts.

MetricDave RochesterAll analysts
Price‑target hit rate53.9%52.4%
Median days to hit target148 days91 days
Calls up after 12 months67.1%64.0%
Median 12‑month return of calls+12.3%+13.4%
Hit rate, last 2 years49.3%—
Average worst drop after a call−18.7%—
Ratings in the sample416—
Stocks covered28—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetDave Rochester
Under 30 days7.0%
30–90 days16.0%
90–180 days32.9%
Over 180 days44.1%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Dave Rochester covers most

StockRatings in the sample
CFR38
MTB35
FLG34
PB29
EWBC27
BKU27
CFG22
ZION21

In the past year Dave’s ratings were 70% Buy, 30% Hold and 0% Sell.

Dave Rochester’s latest ratings

DateStockActionRatingPrice target
Aug 19, 2026EWBCReiterated: BuyBuy$152.00
Aug 19, 2026CFGReiterated: BuyBuy$84.00
Aug 19, 2026MTBReiterated: BuyBuy$285.00
Aug 19, 2026HOMBReiterated: HoldHold$31.00
Aug 19, 2026LOBReiterated: HoldHold$45.00
Aug 6, 2026FLGReiterated: BuyBuy$17.00
Jul 22, 2026EWBCReiterated: BuyBuy$150.00
Jul 20, 2026RFReiterated: BuyBuy$35.00
Jul 16, 2026HOMBReiterated: HoldHold$30.00
Jul 15, 2026RFReiterated: BuyBuy$34.00
Jul 15, 2026ZIONReiterated: BuyBuy$80.00
Jul 15, 2026LOBReiterated: HoldHold$44.00
  • Aug 19, 2026
    Stock
    EWBC
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $152.00
  • Aug 19, 2026
    Stock
    CFG
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $84.00
  • Aug 19, 2026
    Stock
    MTB
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $285.00
  • Aug 19, 2026
    Stock
    HOMB
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $31.00
  • Aug 19, 2026
    Stock
    LOB
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $45.00
  • Aug 6, 2026
    Stock
    FLG
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $17.00
  • Jul 22, 2026
    Stock
    EWBC
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $150.00
  • Jul 20, 2026
    Stock
    RF
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $35.00
  • Jul 16, 2026
    Stock
    HOMB
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $30.00
  • Jul 15, 2026
    Stock
    RF
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $34.00
  • Jul 15, 2026
    Stock
    ZION
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $80.00
  • Jul 15, 2026
    Stock
    LOB
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $44.00

Dave’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Dave Rochester’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Dave Rochester ranks #861 of 1,000 with a 4.6★ rating. 53.9% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 67.1% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Dave Rochester’s success rate is 61.8% by the ranking source and 53.9% by Exent’s price-target hit-rate backtest, with a median of 148 days to reach a target.

Dave Rochester (Cantor Fitzgerald) covers 28 stocks, mostly in financials. The most frequently rated are CFR, MTB, FLG, PB, EWBC.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.